… mechanisms underlying the appearance of levodopa-induced dyskinesia. Dr. Carta's recent work on the role of the serotonin system in dyskinesia has identified a possible new therapeutic target for the management of levodopa-induced dyskinesia. In late 2010, Dr. Carta obtained a permanent …

… therapeutics for Parkinson’s disease and levodopa-induced dyskinesia. Dr. Mabrouk develops innovative techniques to … of Michigan. Dr. Mabrouk is also recipient of a 2013 Dyskinesia Challenge grant award from The Michael J. Fox … to assess the effects of oxytocin on levodopa-induced dyskinesia. Finally, Dr. Mabrouk is co-investigator on a R01 …

… requires higher levodopa doses, side effects -- including dyskinesia (irregular, involuntary, uncontrolled movement) … individuals may not tolerate a dose reduction, preferring dyskinesia to other symptoms.) Levodopa always causes dyskinesia. Although most people with PD eventually develop …

… of the first development of a drug against levodopa-induced dyskinesias which completed clinical development. In 2001, … work on the development of Flibanserin in levodopa-induced dyskinesias. …

… on a new combination of meds that reduced what is called dyskinesias which I had really bad earlier which was [moves … had Parkinson's and took Parkinson's medications that had dyskinesias, that it worked effectively on a large amount of … So it eventually got repurposed...well now I have less dyskinesia and don't get the flu. So that's kinda nice. This …

… investigations into novel aspects of the development of dyskinesias (the disruptive movements that are one of the … PhD, previously found that serotonin neurons play a role in dyskinesia. Dr. Björklund now seeks to show that these neurons may underlie a special kind of dyskinesia, also seen in some patients who received …